Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer	Abdominal Neoplasms, Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, appendiceal neoplasm, bile duct cancer, bile duct disorder, bile duct neoplasm, biliary tract disorder, carcinoma, cecal disorder, cecal neoplasm, cholangiocarcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, gastric cancer, gastric neoplasm, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, peritoneal neoplasm, rectal disorder, stomach disorder	Active, not recruiting	Phase 1	2026-07-13		NCT05277766

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kom Op Tegen Kanker	20
University Ghent	108
University Hospital, Ghent	163

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
UZ Ghent	Ghent	Belgium	3